We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
(-17%)
Cap. Flow
-$2.03B
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$354M |
| 2 |
Verizon
VZ
|
+$307M |
| 3 |
HCA Healthcare
HCA
|
+$256M |
| 4 |
Marathon Petroleum
MPC
|
+$239M |
| 5 |
Comcast
CMCSA
|
+$231M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$361M |
| 2 |
Texas Instruments
TXN
|
+$333M |
| 3 |
LyondellBasell Industries
LYB
|
+$305M |
| 4 |
WCG
Wellcare Health Plans, Inc.
WCG
|
+$298M |
| 5 |
Northrop Grumman
NOC
|
+$282M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.11% |
| 2 | Technology | 18.25% |
| 3 | Consumer Discretionary | 14.02% |
| 4 | Industrials | 10.23% |
| 5 | Financials | 9.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ACOR
1151
DELISTED
Acorda Therapeutics
ACOR
| $2.59M | ﹤0.01% |
1,386
+374
| +37% | +$814K |
|
|
HSII
1152
DELISTED
Heidrick & Struggles
HSII
| $2.57M | ﹤0.01% |
82,302
+15,624
| +23% | +$511K |
|
1153
Revvity
RVTY
$12.9B
| $2.55M | ﹤0.01% |
32,433
-10,839
| -25% | -$915K |
|
|
FNHC
1154
DELISTED
FedNat Holding Company Common Stock
FNHC
| $2.55M | ﹤0.01% |
127,800
+36,412
| +40% | +$799K |
|
|
LION
1155
DELISTED
Fidelity Southern Corporation
LION
| $2.54M | ﹤0.01% |
97,744
-38,354
| -28% | -$904K |
|
1156
Banner Corp
BANR
$2.43B
| $2.54M | ﹤0.01% |
47,516
-1,078
| -2% | -$62.6K |
|
|
SPTN
1157
DELISTED
SpartanNash
SPTN
| $2.54M | ﹤0.01% |
147,929
+81,552
| +123% | +$1.48M |
|
1158
Vicor
VICR
$9.63B
| $2.54M | ﹤0.01% |
67,253
+23,818
| +55% | +$870K |
|
1159
J. Jill
JILL
$279M
| $2.54M | ﹤0.01% |
113,532
+28,457
| +33% | +$652K |
|
1160
iShares MSCI Thailand ETF
THD
$357M
| $2.54M | ﹤0.01% |
30,659
-626
| -2% | -$54.3K |
|
1161
Alexandria Real Estate Equities
ARE
$8.32B
| $2.53M | ﹤0.01% |
21,983
-4,978
| -18% | -$607K |
|
1162
Factset
FDS
$10.1B
| $2.53M | ﹤0.01% |
12,640
-29
| -0.2% | -$6.39K |
|
1163
Olin
OLN
$2.15B
| $2.52M | ﹤0.01% |
125,435
-823,955
| -87% | -$17.6M |
|
|
CALY
1164
Callaway Golf Company
CALY
$3.04B
| $2.52M | ﹤0.01% |
164,793
+92,632
| +128% | +$1.85M |
|
1165
TransUnion
TRU
$15.2B
| $2.52M | ﹤0.01% |
44,364
-277,586
| -86% | -$17.7M |
|
1166
Arcosa
ACA
$7.11B
| $2.52M | ﹤0.01% |
+90,870
| New | +$2.5M |
|
1167
Signet Jewelers
SIG
$3.67B
| $2.52M | ﹤0.01% |
79,186
+35,135
| +80% | +$1.76M |
|
|
ESGR
1168
DELISTED
Enstar Group
ESGR
| $2.5M | ﹤0.01% |
14,948
-3,222
| -18% | -$583K |
|
1169
Hooker Furnishings Corp
HOFT
$159M
| $2.5M | ﹤0.01% |
94,721
-50,329
| -35% | -$1.5M |
|
1170
La-Z-Boy
LZB
$1.66B
| $2.5M | ﹤0.01% |
90,041
-47,048
| -34% | -$1.33M |
|
1171
Silgan Holdings
SLGN
$4.35B
| $2.49M | ﹤0.01% |
105,467
+24,774
| +31% | +$623K |
|
1172
Coca-Cola Femsa
KOF
$22.9B
| $2.49M | ﹤0.01% |
40,909
-3,155
| -7% | -$191K |
|
1173
W.P. Carey
WPC
$16.1B
| $2.48M | ﹤0.01% |
38,748
+391
| +1% | +$25.4K |
|
1174
TriCo Bancshares
TCBK
$1.82B
| $2.46M | ﹤0.01% |
72,865
-59,007
| -45% | -$2.12M |
|
|
NUAN
1175
DELISTED
Nuance Communications, Inc.
NUAN
| $2.46M | ﹤0.01% |
214,522
+136,698
| +176% | +$1.92M |
|
Similar funds
VGA
AQR Capital Management's Q4 2018 Portfolio in Review
As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.
- AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
- AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
- AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
- AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
- AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
- AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
- AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.
Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.